-
Mashup Score: 19Tonsils are major sites of persistence of SARS-CoV-2 in children | Microbiology Spectrum - 7 month(s) ago
This study shows that SRS-CoV-2 of different lineages can infect tonsils and adenoids in one quarter of children undergoing tonsillectomy. These findings bring advancement to the area of SARS-CoV-2 pathogenesis, by showing that tonsils may be sites of …
Source: journals.asm.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 9Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines - 1 year(s) ago
The FDA amended the EUAs of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
Categories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 2
Thought COVID was done with the surprises? Not yet, apparently. Those itchy, red eyes you have that you assumed were just the start of allergy season? It could very well be something called “Arcturus” instead. XBB.1.16, a subvariant of the Omicron variant of the COVID-19 virus that has acquired that unusual stellar label, appears to be spreading quickly in some…
Source: NBC New YorkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Information for Persons Who Are Immunocompromised ... - 1 year(s) ago
This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5
Eli Lilly and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
Source: ReutersCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10
New strains seem to evade treatments used for vulnerable patients — and could complicate the latest White House messaging strategy on Covid.
Source: POLITICOCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 23Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose - 2 year(s) ago
The FDA authorized bivalent formulations of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for use as a single booster dose.
Categories: Hem/Oncs, Latest HeadlinesTweet-
🚨🥁Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose https://t.co/h5EoIorxUu
-
-
Mashup Score: 84Fauci tests positive for virus, has mild COVID-19 symptoms - 2 year(s) ago
Dr. Anthony Fauci, the face of America’s pandemic response through two White House administrations, has tested positive for the coronavirus. The 81-year-old Fauci, who is fully vaccinated and has received two booster shots, was experiencing mild COVID-19 symptoms, according to a statement Wednesday from the National Institutes of Health.
Source: AP NEWSCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 47How Rapid Reinfection Has Changed the Covid Fight - 2 year(s) ago
New variants can infect people who had Covid-19 as recently as a few months ago.
Source: The New RepublicCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 23
As of 12 May 2022, ECDC has reclassified Omicron sub-lineages BA.4 and BA.5 from variants of interest to variants of concern.
Categories: Latest Headlines, Oncologists1Tweet
Cross-sectional study finds #SARSCoV2 in tonsils/adenoids in 1/4 of kids at tonsillectomy for sleep apnea or chronic tonsillitis. In 53% of infected samples, there was active replication (& a variety of #CovidVariants). #COVID19 #LongCovid #MedTwitter https://t.co/YuxmH8fPCe